Tufton Capital Management Merck & Co., Inc. Transaction History

Tufton Capital Management

$532 Million
Q3 2024

A detailed history of Tufton Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Tufton Capital Management holds 104,119 shares of MRK stock, worth $10.4 Million. This represents 2.22% of its overall portfolio holdings.

Number of Shares

104,119

Previous 105,369 1.19%

Holding current value

$10.4 Million

Previous $13 Million 9.36%

% of portfolio

2.22%

Previous 2.54%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$111.15 - $128.97 $138,937 - $161,212	-1,250 Reduced 1.19%	104,119 $11.8 Million
Q2 2024 Jul 31, 2024	SELL	$123.8 - $132.96 $84,803 - $91,077	-685 Reduced 0.65%	105,369 $13 Million
Q1 2024 May 07, 2024	SELL	$113.24 - $131.95 $39,747 - $46,314	-351 Reduced 0.33%	106,054 $14 Million
Q4 2023 Jan 31, 2024	SELL	$100.18 - $109.02 $142,556 - $155,135	-1,423 Reduced 1.32%	106,405 $11.6 Million
Q3 2023 Oct 30, 2023	SELL	$102.95 - $114.33 $52,813 - $58,651	-513 Reduced 0.47%	107,828 $11.1 Million
Q2 2023 Jul 28, 2023	SELL	$108.61 - $118.38 $363,300 - $395,981	-3,345 Reduced 3.0%	108,341 $12.5 Million
Q1 2023 Apr 19, 2023	SELL	$102.94 - $114.86 $1.69 Million - $1.89 Million	-16,456 Reduced 12.84%	111,686 $11.9 Million
Q4 2022 Jan 26, 2023	BUY	$87.44 - $112.11 $52,988 - $67,938	606 Added 0.48%	128,142 $0
Q3 2022 Oct 21, 2022	SELL	$84.53 - $94.96 $3.64 Million - $4.09 Million	-43,026 Reduced 25.23%	127,536 $11 Million
Q2 2022 Jul 20, 2022	SELL	$83.49 - $94.64 $8,682 - $9,842	-104 Reduced 0.06%	170,562 $15.6 Million
Q1 2022 Apr 25, 2022	SELL	$73.51 - $82.4 $153,341 - $171,886	-2,086 Reduced 1.21%	170,666 $14 Million
Q4 2021 Jan 28, 2022	BUY	$72.28 - $90.54 $140,656 - $176,190	1,946 Added 1.14%	172,752 $13.2 Million
Q3 2021 Oct 21, 2021	SELL	$71.68 - $78.83 $47,523 - $52,264	-663 Reduced 0.39%	170,806 $12.8 Million
Q2 2021 Jul 29, 2021	SELL	$70.31 - $77.77 $316,465 - $350,042	-4,501 Reduced 2.56%	171,469 $13.3 Million
Q1 2021 Apr 22, 2021	BUY	$68.86 - $81.11 $260,703 - $307,082	3,786 Added 2.2%	175,970 $13.6 Million
Q4 2020 Feb 01, 2021	BUY	$71.77 - $79.65 $61,722 - $68,499	860 Added 0.5%	172,184 $14.1 Million
Q3 2020 Oct 23, 2020	SELL	$73.18 - $82.95 $273,693 - $310,233	-3,740 Reduced 2.14%	171,324 $14.2 Million
Q2 2020 Jul 27, 2020	BUY	$70.42 - $80.13 $97,742 - $111,220	1,388 Added 0.8%	175,064 $13.5 Million
Q1 2020 Apr 23, 2020	BUY	$63.36 - $87.82 $169,361 - $234,742	2,673 Added 1.56%	173,676 $13.4 Million
Q4 2019 Jan 24, 2020	SELL	$77.58 - $87.54 $131,187 - $148,030	-1,691 Reduced 0.98%	171,003 $15.6 Million
Q3 2019 Oct 25, 2019	SELL	$76.08 - $82.93 $13.2 Million - $14.4 Million	-173,901 Closed	0 $0
Q2 2019 Jul 26, 2019	SELL	$69.84 - $81.59 $6,914 - $8,077	-99 Reduced 0.06%	173,901 $14.6 Million
Q1 2019 Apr 29, 2019	SELL	$69.58 - $79.36 $94,141 - $107,374	-1,353 Reduced 0.77%	174,000 $14.5 Million
Q4 2018 Jan 28, 2019	SELL	$65.24 - $75.71 $45,341 - $52,618	-695 Reduced 0.39%	175,353 $13.4 Million
Q3 2018 Oct 26, 2018	SELL	$57.69 - $67.84 $634,705 - $746,375	-11,002 Reduced 5.88%	176,048 $12.5 Million
Q2 2018 Aug 06, 2018	SELL	$50.83 - $59.72 $138,257 - $162,438	-2,720 Reduced 1.43%	187,050 $11.4 Million
Q1 2018 Apr 23, 2018	BUY	$50.96 - $59.23 $137,184 - $159,447	2,692 Added 1.44%	189,770 $10.3 Million
Q4 2017 Jan 26, 2018	BUY	$51.62 - $61.64 $158,112 - $188,803	3,063 Added 1.66%	187,078 $10.5 Million
Q3 2017 Oct 20, 2017	BUY	$58.67 - $63.13 $10.8 Million - $11.6 Million	184,015	184,015 $11.8 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tufton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Tufton Capital Management with notifications on news.

Account

Tufton Capital Management Merck & Co., Inc. Transaction History